We are thrilled to announce that Novamab, a global leader in single-domain antibody therapeutics, will unveil a groundbreaking portfolio of oral, bispecific, and inhaled single-domain antibody products at the 9th BFC Global Healthcare Business Development & Investment Conference. These innovative solutions are poised to transform the landscape of inflammatory and immunological therapies.

Join us for this incredible opportunity to engage in transformative discussions shaping the future of healthcare! Don’t miss our showcase of pioneering advancements that are set to redefine patient care.

Novamab’s Road Show Time: Sun, Jan 11, 2026, 3:30-3:45 PM PT (15 min)

Let's connect at this conference.